Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | |
---|---|---|---|---|
15.05. | Cadrenal Therapeutics advances in tecarfarin production | 2 | Investing.com | |
08.05. | Cadrenal Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | |
08.05. | Cadrenal Therapeutics, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | |
17.04. | Cadrenal Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | |
13.03. | Cadrenal Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | |
CADRENAL THERAPEUTICS Aktie jetzt für 0€ handeln | ||||
13.03. | Cadrenal Therapeutics, Inc. - 10-K, Annual Report | 1 | SEC Filings | |
13.03. | Cadrenal Therapeutics GAAP EPS of -$8.73 misses by $1.14 | 3 | Seeking Alpha | |
04.03. | Cadrenal kooperiert mit Abbott bei Herzgeräte-Studie | 8 | Investing.com Deutsch | |
04.03. | Cadrenal partners with Abbott for heart device trial | 1 | Investing.com | |
04.03. | Cadrenal Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | |
07.02. | Cadrenal Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | |
06.02. | Cadrenal Therapeutics ernennt neuen Chief Medical Officer | 1 | Investing.com Deutsch | |
03.02. | Cadrenal Therapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | |
07.11.24 | Cadrenal Therapeutics, Inc.: Cadrenal Therapeutics Provides Third-quarter Corporate Update | 120 | PR Newswire | |
07.08.24 | Cadrenal Therapeutics, Inc.: Cadrenal Therapeutics Provides Second Quarter 2024 Corporate Update | 188 | PR Newswire | |
06.08.24 | Cadrenal Therapeutics, Inc.: Cadrenal Therapeutics and Abbott Initiate Collaborative Effort to Advance Novel Anticoagulant Tecarfarin for Patients with LVADs | 166 | PR Newswire |